Radiopharmaceuticals Market Report – Research, Industry Analysis Reports and Market Demands

Global Radiopharmaceuticals Market Size study, by Radioisotope (Technetium-99, Gallium-67, Iodine-123, 18F, Rubidium-82, Yttrium-90, Lutetium-177), by Source (Nuclear Reactors, Cyclotrons), by Application (Cardiology, Gastroenterology, Oncology, Nephrology, Neurology, Immunology, Others), by End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and Regional Forecasts 2019-2026

Request for Sample of this report

Buy now

Table of Content

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
- 1.3.1. Radiopharmaceuticals Market, by Radioisotope, 2016-2026 (USD Billion)
- 1.3.2. Radiopharmaceuticals Market, by Source, 2016-2026 (USD Billion)
- 1.3.3. Radiopharmaceuticals Market, by Application, 2016-2026 (USD Billion)
- 1.3.4. Radiopharmaceuticals Market, by End-User, 2016-2026 (USD Billion)
- 1.3.5. Radiopharmaceuticals Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Radiopharmaceuticals Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Radiopharmaceuticals Market Dynamics

3.1. See Saw Analysis
- 3.1.1. Market Drivers
- 3.1.2. Market Challenges
- 3.1.3. Market Opportunities

Chapter 4. Radiopharmaceuticals Market Industry Analysis

4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Buyers
- 4.1.2. Bargaining Power of Suppliers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
- 4.2.1. Political Scenario
- 4.2.2. Economic Scenario
- 4.2.3. Social Scenario
- 4.2.4. Technological Scenario
4.3. Key Buying Criteria
4.4. Regulatory Framework
4.5. Investment Vs Adoption Scenario
4.6. Analyst Recommendation & Conclusion

Chapter 5. Radiopharmaceuticals Market, by Radioisotope

Description

Global Radiopharmaceuticals Market valued approximately USD 5.72 billion in 2018 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2019-2026. The Radiopharmaceuticals Market is continuously growing in the global scenario at significant pace. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. Increasing incidence of cardiovascular diseases, growing preference for PET and SPET scans, rise in consciousness about positive effects and enhancements in radiotracers are the substantial driving factors of the market during the forecast period. Moreover, increase in use of radiopharmaceuticals in neurological applications are the factors that likely to create numerous opportunity in the near future. However, scarcity of radioisotopes, strict regulatory standards and high cost of the procedure are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Radiopharmaceuticals Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to presence of excellent research facilities and rising healthcare expenditure in the region. Europe is estimated to grow at stable growth rate in the global Radiopharmaceuticals market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising demand for PET and SPECT devices and rising patient awareness levels pertaining to cardiovascular diseases and oncology in the region.

The major market player included in this report are:
Advanced Accelerator Applications (AAA)
Bayer AG
Eckert & Ziegler
GE Healthcare
IBA Radiopharma Solutions
Lantheus Holdings Inc.
Mallinckrodt Plc
Nordion Inc.
Positron Corporation
Siemens Healthineers

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:

Technetium-99
Gallium-67
Iodine-123
18F
Rubidium-82
Yttrium-90
Lutetium-177

By Source:

Nuclear Reactors
Cyclotrons

By Application:
Cardiology
Gastroenterology
Oncology
Nephrology
Neurology
Immunology
Others

By End-User:

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Buy now

Request for Sample of this report

TABLE OF CONTENTS

Chapter 1. Executive Summary

Chapter 2. Radiopharmaceuticals Market Definition and Scope

Chapter 3. Radiopharmaceuticals Market Dynamics

Chapter 4. Radiopharmaceuticals Market Industry Analysis

Chapter 5. Radiopharmaceuticals Market, by Radioisotope

Chapter 6. Radiopharmaceuticals Market, by Source

Chapter 7. Radiopharmaceuticals Market, by Application

Chapter 8. Radiopharmaceuticals Market, by End-User

Chapter 9. Radiopharmaceuticals Market, by Regional Analysis

Chapter 10. Competitive Intelligence

Chapter 11. Research Process